ArticleClinical pharmacology and therapeutics2026
Use of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors in Incident Hyponatremia in Patients with Type 2 Diabetes: Multicenter Target Trial Emulations.
Ying-Hsuan Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.